Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Delayed Nasdaq  -  04:00 2022-09-27 pm EDT
130.30 USD   +2.08%
11:14aEuropean ADRs Climb Higher in Tuesday Trading
MT
08:18aBIONTECH : Berenberg remains its Buy rating
MD
09/26Health Care Down as Investors Flee Defensive Sectors -- Health Care Roundup
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech : Deutsche Bank Starts BioNTech at Hold with $250 Price Target

10/22/2021 | 10:54am EDT


© MT Newswires 2021
All news about BIONTECH SE
11:14aEuropean ADRs Climb Higher in Tuesday Trading
MT
08:18aBIONTECH : Berenberg remains its Buy rating
MD
09/26Health Care Down as Investors Flee Defensive Sectors -- Health Care Roundup
DJ
09/26European ADRs Decline in Monday Trading
MT
09/26Sector Update: Health Care Stocks Mixed Premarket Monday
MT
09/26Pfizer, BioNTech Seek FDA Approval for COVID-19 Vaccine Targeting Omicron Subvariants i..
MT
09/26Trending : Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
DJ
09/26Pfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine Fo..
MT
09/26Pfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
09/26Pfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specif..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2022 15 862 M 15 226 M 15 226 M
Net income 2022 8 582 M 8 238 M 8 238 M
Net cash 2022 16 118 M 15 472 M 15 472 M
P/E ratio 2022 4,06x
Yield 2022 -
Capitalization 32 989 M 31 665 M 31 665 M
EV / Sales 2022 1,06x
EV / Sales 2023 0,95x
Nbr of Employees 3 082
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 135,75 €
Average target price 213,96 €
Spread / Average Target 57,6%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE-50.48%31 021
GILEAD SCIENCES, INC.-13.74%78 135
REGENERON PHARMACEUTICALS, INC.10.05%73 350
VERTEX PHARMACEUTICALS29.66%70 983
WUXI APPTEC CO., LTD.-39.08%28 544
GENMAB A/S-6.73%20 742